tiprankstipranks
Grace Therapeutics, Inc. (GRCE)
:GRCE
US Market
Holding GRCE?
Track your performance easily

Grace Therapeutics (GRCE) Ownership - Who Owns Grace Therapeutics?

1,146 Followers

Grace Therapeutics (GRCE) Ownership Overview

9.46%2.22%88.32%
9.46% Other Institutional Investors
2.22% ETFs
88.32% Public Companies and Individual Investors
The ownership structure of Grace Therapeutics (GRCE) stock is a mix of institutional, retail, and individual investors. , and 88.32% is owned by Public Companies and Individual Investors.
The ownership structure of Grace Therapeutics (GRCE) stock is a mix of institutional, retail, and individual investors. Approximately 90.54% of the company’s stock is owned by Institutional Investors, 9.46% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
225,000Institution2.22%787,500

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
225,000Institution2.22%756,000

FAQ

Who Owns Grace Therapeutics, Inc. (GRCE)?
Currently, no data Available
What percentage of Grace Therapeutics, Inc. (GRCE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.46% of Grace Therapeutics, Inc. (GRCE) stock is held by institutional investors.
    What percentage of Grace Therapeutics, Inc. (GRCE) stock is held by retail investors?
    According to the latest TipRanks data, approximately 88.32% of Grace Therapeutics, Inc. (GRCE) stock is held by retail investors.
      Who owns the most shares of Grace Therapeutics, Inc. (GRCE)?
      Vanguard owns the most shares of Grace Therapeutics, Inc. (GRCE).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis